Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this research study is to evaluate whether Abraxane and gemcitabine are
effective in treating patients with operable pancreatic cancer.